Evidence map›Paper›PMID 35845216›Full record

ArticleEJHaem2021

Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum.

Aya Nakaya, Hirohiko Shibayama, Eiji Nakatani, Yuji Shimura, Satoru Kosugi, Hirokazu Tanaka, Shin-Ichi Fuchida, Junya Kanda, Nobuhiko Uoshima, Hitomi Kaneko and 12 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 2 countries.

Aya NakayaFirst Department of Internal Medicine Kansai Medical University Osaka Japan.ORCID https://orcid.org/0000-0001-8365-3987
Hirohiko ShibayamaDepartment of Hematology and Oncology Osaka University Graduate School of Medicine Osaka Japan.
Eiji NakataniGraduate School of Public Health Shizuoka Graduate University of Public Health Shizuoka Japan.
Yuji ShimuraDivision of Hematology and Oncology, Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0001-9309-7902
Satoru KosugiDepartment of Internal Medicine (Hematology) Toyonaka Municipal Hospital Osaka Japan.
Hirokazu TanakaDepartment of Hematology and Rheumatology Kindai University Faculty of Medicine Osaka Japan.
Shin-Ichi FuchidaDepartment of Hematology Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center Kyoto Japan.ORCID https://orcid.org/0000-0002-4147-9113
Junya KandaDepartment of Hematology and Oncology, Graduate School of Medicine Kyoto University Kyoto Japan.ORCID https://orcid.org/0000-0002-6704-3633
Nobuhiko UoshimaDepartment of Hematology Japanese Red Cross Kyoto Daini Hospital Kyoto Japan.
Hitomi KanekoDepartment of Hematology Japanese Red Cross Osaka Hospital Osaka Japan.
Kazunori ImadaDepartment of Hematology Japanese Red Cross Osaka Hospital Osaka Japan.
Kensuke OhtaHematology Ohta Clinic Shinsaibashi Osaka Japan.
Tomoki ItoFirst Department of Internal Medicine Kansai Medical University Osaka Japan.
Hideo YagiDepartment of Hematology and Oncology Nara Prefecture General Medical Center Nara Japan.
Satoshi YoshiharaDivision of Hematology, Department of Internal Medicine Hyogo College of Medicine Hyogo Japan.ORCID https://orcid.org/0000-0002-8537-2422
Masayuki HinoDepartment of Hematology Osaka City University Graduate School of Medicine Osaka Japan.
Chihiro ShimazakiDepartment of Hematology Japan Community Health Care Organization Kyoto Kuramaguchi Medical Center Kyoto Japan.
Akifumi Takaori-KondoDepartment of Hematology and Oncology, Graduate School of Medicine Kyoto University Kyoto Japan.
Junya KurodaDivision of Hematology and Oncology, Department of Medicine Kyoto Prefectural University of Medicine Kyoto Japan.ORCID https://orcid.org/0000-0001-6130-1550
Itaru MatsumuraDepartment of Hematology and Rheumatology Kindai University Faculty of Medicine Osaka Japan.
Yuzuru KanakuraDepartment of Hematology Sumitomo Hospital Osaka Japan.
Shosaku NomuraFirst Department of Internal Medicine Kansai Medical University Osaka Japan.
Kansai Vocational College of Medicine · JPKansai Medical University · JPKyoto Medical Center · JPKyoto Prefectural University of Medicine · JPKyoto University · JPHyogo Medical University · JPNational Archives and Records Administration · USOsaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A total of 129 symptomatic patients with multiple myeloma (MM) who underwent high-dose chemotherapy with autologous stem cell transplantation (HDT/ASCT) were analyzed. The 4-year overall survival (OS) of patients with maintenance (

Indexed as

autologous stem cell transplantationlenalidomidemaintenance therapyretrospectivesymptomatic multiple myeloma

Identifiers

PMID35845216
PMCPMC9175982
OpenAlexW3208917228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.